VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 55 filers reported holding VOYAGER THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,569,000 | +190.6% | 81,968 | +42.7% | 0.00% | – |
| Q4 2018 | $540,000 | -81.6% | 57,425 | -62.9% | 0.00% | -100.0% |
| Q3 2018 | $2,932,000 | +84.9% | 154,924 | +90.8% | 0.00% | 0.0% |
| Q2 2018 | $1,586,000 | +131.5% | 81,185 | +122.5% | 0.00% | – |
| Q1 2018 | $685,000 | +13.0% | 36,482 | 0.0% | 0.00% | – |
| Q4 2017 | $606,000 | -21.1% | 36,482 | -2.2% | 0.00% | -100.0% |
| Q3 2017 | $768,000 | +129.9% | 37,295 | 0.0% | 0.00% | – |
| Q2 2017 | $334,000 | -24.4% | 37,295 | +11.8% | 0.00% | – |
| Q1 2017 | $442,000 | -8.7% | 33,356 | -12.2% | 0.00% | – |
| Q4 2016 | $484,000 | +3.4% | 37,978 | -2.5% | 0.00% | – |
| Q3 2016 | $468,000 | -7.7% | 38,936 | -15.6% | 0.00% | – |
| Q2 2016 | $507,000 | +382.9% | 46,106 | +283.0% | 0.00% | – |
| Q1 2016 | $105,000 | -60.2% | 12,039 | 0.0% | 0.00% | – |
| Q4 2015 | $264,000 | – | 12,039 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,851,507 | $29,849,179 | 1.01% |
| ARMISTICE CAPITAL, LLC | 4,178,000 | $32,379,500 | 0.50% |
| SummerHaven Investment Management, LLC | 72,779 | $564,037 | 0.41% |
| GLOBEFLEX CAPITAL L P | 453,595 | $3,515,361 | 0.41% |
| Ikarian Capital, LLC | 305,857 | $2,370,392 | 0.28% |
| Hillsdale Investment Management Inc. | 367,590 | $2,848,824 | 0.26% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 103,966 | $805,737 | 0.24% |
| Parkman Healthcare Partners LLC | 60,322 | $467,496 | 0.09% |
| Inspire Investing, LLC | 82,656 | $640,584 | 0.08% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 52,500 | $406,875 | 0.08% |